Quick answer: In the Mounjaro vs Ozempic comparison, Mounjaro (tirzepatide) produces a bigger drop in HbA1c (up to 2.5%) and more weight loss (15-20%) than Ozempic (semaglutide, up to 1.5% HbA1c, 10-15% weight loss), but it costs nearly double 14,000-17,500 a month versus Ozempics 8,800-11,175
For patients unable to achieve this target initially, any increase in physical activity offers benefit, and gradual progression should be encouraged
The state of play in 2026 For years, clinicians compared tirzepatide and semaglutide across separate trials with different patient populations, different endpoints, and different study designs
Notch signaling in development, tissue homeostasis, and disease